Previous 10 | Next 10 |
LAKEWOOD, Colo., Feb. 03, 2022 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced results for its third fiscal quarter (“3Q22”) and nine months ended December 31, 2021. Financial highlights for the quarter and nine months ended December 31, 2021 ...
Mesa Laboratories (NASDAQ:MLAB): Q2 Non-GAAP EPS of $1.87 beats by $0.80; GAAP EPS of $0.70 beats by $0.45. Revenue of $35.84M (+12.5% Y/Y) beats by $0.61M. Press Release For further details see: Mesa Laboratories EPS beats by $0.80, beats on revenue
LAKEWOOD, Colo., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) today reported results for its second fiscal quarter (“2Q22”) and six months ended September 30, 2021. Financial highlights for the quarter and six months ended September 30, 2021 ...
LAKEWOOD, Colo., Oct. 29, 2021 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) announced the appointment of Shiraz Ladiwala to its Board of Directors, effective October 28, 2021. Shiraz previously worked in leadership roles at Thermo Fisher Scientific and retired on August 31, 202...
LAKEWOOD, Colo., Oct. 20, 2021 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced that it has completed the previously announced acquisition of Agena Biosciences, Inc. With this highly strategic acquisition, Agena’s innovative approach to molecular diagnostics ...
The following slide deck was published by Mesa Laboratories, Inc. in conjunction with this event. For further details see: Mesa Laboratories (MLAB) Acquires Agena Bioscience
LAKEWOOD, Colo., Sept. 14, 2021 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (“we”, “us”, “our”, “Mesa” or the “Company”), a global leader in the design and manufacturing of critical quality control solutions...
LAKEWOOD, Colo., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) today reported results for its first fiscal quarter (“1Q22”). Financial highlights for the quarter ended June 30, 2021 as compared to last year: Revenues increased 17% ...
Mesa Laboratories (MLAB): Q4 Non-GAAP EPS of $1.98 beats by $0.91; GAAP EPS of $0.74 beats by $0.48.Revenue of $37.96M (+11.0% Y/Y) beats by $2.95M.Press Release For further details see: Mesa Laboratories EPS beats by $0.91, beats on revenue
InvestorPlace - Stock Market News, Stock Advice & Trading Tips After a volatile 2020, the U.S. economy is ready for a massive turnaround this year. The S&P 500 index dropped more than 30% in just 30 days in the first quarter of 2020. However, this year the benchmark gauge has sta...
News, Short Squeeze, Breakout and More Instantly...
Mesa Laboratories Inc. Company Name:
MLAB Stock Symbol:
NASDAQ Market:
Mesa Laboratories Inc. Website:
2024-07-03 04:14:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
LAKEWOOD, Colo., June 05, 2024 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced results for its fourth fiscal quarter (“4Q24”) and fiscal year ( ...